Bristol-Myers Squibb describes potent and selective beta3-adrenoceptor agonist Oct. 25, 1996 No Comments
Polypeptide product of DRA gene as potential therapy in colorectal carcinoma available for licensing Oct. 25, 1996 No Comments
RSS